Evaluation of a class of isatinoids identified from a high-throughput screen of human kinase inhibitors as anti-Sleeping Sickness agents

New treatments are needed for neglected tropical diseases (NTDs) such as Human African trypanosomiasis (HAT), Chagas disease, and schistosomiasis. Through a whole organism high-throughput screening campaign, we previously identified 797 human kinase inhibitors that grouped into 59 structural cluster...

Full description

Saved in:
Bibliographic Details
Published in:PLoS neglected tropical diseases 2019-02, Vol.13 (2), p.e0007129-e0007129
Main Authors: Klug, Dana M, Diaz-Gonzalez, Rosario, Pérez-Moreno, Guiomar, Ceballos-Pérez, Gloria, García-Hernández, Raquel, Gomez-Pérez, Veronica, Ruiz-Pérez, Luis Miguel, Rojas-Barros, Domingo I, Gamarro, Francisco, González-Pacanowska, Dolores, Martínez-Martínez, María S, Manzano, Pilar, Ferrins, Lori, Caffrey, Conor R, Navarro, Miguel, Pollastri, Michael P
Format: Article
Language:English
Subjects:
African trypanosomiasis
Antibiotics
Biology
Biology and Life Sciences
Chagas disease
Chemistry
Clinical trials
Clusters
Dosage and administration
Drug therapy
Drugs
Excretion
High-throughput screening
Identification
Inhibitors
Kinase inhibitors
Kinases
Medical treatment
Medicine and Health Sciences
Metabolism
Nervous system
Parasites
Parasitic diseases
Pharmacokinetics
Pharmacology
Schistosomiasis
Tropical climate
Tropical diseases
Trypanosomiasis
Vector-borne diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c624t-e32f560eeee03fec1864aad89856b41fac033f58035eaf31e524259db0d5147b3
cites cdi_FETCH-LOGICAL-c624t-e32f560eeee03fec1864aad89856b41fac033f58035eaf31e524259db0d5147b3
container_end_page e0007129
container_issue 2
container_start_page e0007129
container_title PLoS neglected tropical diseases
container_volume 13
creator Klug, Dana M
Diaz-Gonzalez, Rosario
Pérez-Moreno, Guiomar
Ceballos-Pérez, Gloria
García-Hernández, Raquel
Gomez-Pérez, Veronica
Ruiz-Pérez, Luis Miguel
Rojas-Barros, Domingo I
Gamarro, Francisco
González-Pacanowska, Dolores
Martínez-Martínez, María S
Manzano, Pilar
Ferrins, Lori
Caffrey, Conor R
Navarro, Miguel
Pollastri, Michael P
description New treatments are needed for neglected tropical diseases (NTDs) such as Human African trypanosomiasis (HAT), Chagas disease, and schistosomiasis. Through a whole organism high-throughput screening campaign, we previously identified 797 human kinase inhibitors that grouped into 59 structural clusters and showed activity against T. brucei, the causative agent of HAT. We herein report the results of further investigation of one of these clusters consisting of substituted isatin derivatives, focusing on establishing structure-activity and -property relationship scope. We also describe their in vitro absorption, distribution, metabolism, and excretion (ADME) properties. For one isatin, NEU-4391, which offered the best activity-property profile, pharmacokinetic parameters were measured in mice.
doi_str_mv 10.1371/journal.pntd.0007129
format article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2252311442</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A576572591</galeid><doaj_id>oai_doaj_org_article_8cc5ddaa83b043e2aaad8dbc1ec31ea7</doaj_id><sourcerecordid>A576572591</sourcerecordid><originalsourceid>FETCH-LOGICAL-c624t-e32f560eeee03fec1864aad89856b41fac033f58035eaf31e524259db0d5147b3</originalsourceid><addsrcrecordid>eNptkm1r1TAUx4sobk6_gWhBEN_0mjRNH94IY0wdDHwxfR1Ok9M2d2lyTdqB38CPbbrbjXtlbaHh9Hf-56H_JHlLyYayin7eutlbMJudndSGEFLRvHmWnNKG8SyvGH9-cD5JXoWwJYQ3vKYvkxNGYpATepr8vbwDM8OknU1dl0IqDYSwHHWIUeu0CqlWaCfdaVRp590YqUH3QzYN3s39sJunNEiPeK8wzCPY9FZbCJhqO-hWT86HFOITRbIbg7jTtk9vtLy1GGtBH9XD6-RFBybgm_V9lvz6evnz4nt2_ePb1cX5dSbLvJgyZHnHS4LxIqxDSeuyAFB1U_OyLWgHkjDW8ZowjtAxijwvct6olihOi6plZ8n7ve7OuCDWJQaR5zxnlBZFHomrPaEcbMXO6xH8H-FAi_uA870AP2lpUNRScqUAataSgmEOSyuqlRRlLA1V1PqyVpvbEZWMk3owR6LHX6weRO_uRMlq1hR1FPi0Cnj3e8YwiVEHicaARTfHvmnNefypOYvoh__Qp6dbqR7iANp2LtaVi6g451XJq7gtGqnNE1S8FY5aOoudjvGjhI8HCQOCmYbgzLwYKxyDxR6U3oXgsXtcBiViMfZD12IxtliNHdPeHS7yMenByewfLE332Q</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2252311442</pqid></control><display><type>article</type><title>Evaluation of a class of isatinoids identified from a high-throughput screen of human kinase inhibitors as anti-Sleeping Sickness agents</title><source>PubMed Central (Open Access)</source><source>Publicly Available Content Database</source><creator>Klug, Dana M ; Diaz-Gonzalez, Rosario ; Pérez-Moreno, Guiomar ; Ceballos-Pérez, Gloria ; García-Hernández, Raquel ; Gomez-Pérez, Veronica ; Ruiz-Pérez, Luis Miguel ; Rojas-Barros, Domingo I ; Gamarro, Francisco ; González-Pacanowska, Dolores ; Martínez-Martínez, María S ; Manzano, Pilar ; Ferrins, Lori ; Caffrey, Conor R ; Navarro, Miguel ; Pollastri, Michael P</creator><contributor>Almeida, Igor C.</contributor><creatorcontrib>Klug, Dana M ; Diaz-Gonzalez, Rosario ; Pérez-Moreno, Guiomar ; Ceballos-Pérez, Gloria ; García-Hernández, Raquel ; Gomez-Pérez, Veronica ; Ruiz-Pérez, Luis Miguel ; Rojas-Barros, Domingo I ; Gamarro, Francisco ; González-Pacanowska, Dolores ; Martínez-Martínez, María S ; Manzano, Pilar ; Ferrins, Lori ; Caffrey, Conor R ; Navarro, Miguel ; Pollastri, Michael P ; Almeida, Igor C.</creatorcontrib><description>New treatments are needed for neglected tropical diseases (NTDs) such as Human African trypanosomiasis (HAT), Chagas disease, and schistosomiasis. Through a whole organism high-throughput screening campaign, we previously identified 797 human kinase inhibitors that grouped into 59 structural clusters and showed activity against T. brucei, the causative agent of HAT. We herein report the results of further investigation of one of these clusters consisting of substituted isatin derivatives, focusing on establishing structure-activity and -property relationship scope. We also describe their in vitro absorption, distribution, metabolism, and excretion (ADME) properties. For one isatin, NEU-4391, which offered the best activity-property profile, pharmacokinetic parameters were measured in mice.</description><identifier>ISSN: 1935-2735</identifier><identifier>ISSN: 1935-2727</identifier><identifier>EISSN: 1935-2735</identifier><identifier>DOI: 10.1371/journal.pntd.0007129</identifier><identifier>PMID: 30735501</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>African trypanosomiasis ; Antibiotics ; Biology ; Biology and Life Sciences ; Chagas disease ; Chemistry ; Clinical trials ; Clusters ; Dosage and administration ; Drug therapy ; Drugs ; Excretion ; High-throughput screening ; Identification ; Inhibitors ; Kinase inhibitors ; Kinases ; Medical treatment ; Medicine and Health Sciences ; Metabolism ; Nervous system ; Parasites ; Parasitic diseases ; Pharmacokinetics ; Pharmacology ; Schistosomiasis ; Tropical climate ; Tropical diseases ; Trypanosomiasis ; Vector-borne diseases</subject><ispartof>PLoS neglected tropical diseases, 2019-02, Vol.13 (2), p.e0007129-e0007129</ispartof><rights>COPYRIGHT 2019 Public Library of Science</rights><rights>2019 Klug et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2019 Klug et al 2019 Klug et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c624t-e32f560eeee03fec1864aad89856b41fac033f58035eaf31e524259db0d5147b3</citedby><cites>FETCH-LOGICAL-c624t-e32f560eeee03fec1864aad89856b41fac033f58035eaf31e524259db0d5147b3</cites><orcidid>0000-0003-2301-2699 ; 0000-0001-9943-7197 ; 0000-0002-8982-0640</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2252311442/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2252311442?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25751,27922,27923,37010,37011,44588,53789,53791,74896</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30735501$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Almeida, Igor C.</contributor><creatorcontrib>Klug, Dana M</creatorcontrib><creatorcontrib>Diaz-Gonzalez, Rosario</creatorcontrib><creatorcontrib>Pérez-Moreno, Guiomar</creatorcontrib><creatorcontrib>Ceballos-Pérez, Gloria</creatorcontrib><creatorcontrib>García-Hernández, Raquel</creatorcontrib><creatorcontrib>Gomez-Pérez, Veronica</creatorcontrib><creatorcontrib>Ruiz-Pérez, Luis Miguel</creatorcontrib><creatorcontrib>Rojas-Barros, Domingo I</creatorcontrib><creatorcontrib>Gamarro, Francisco</creatorcontrib><creatorcontrib>González-Pacanowska, Dolores</creatorcontrib><creatorcontrib>Martínez-Martínez, María S</creatorcontrib><creatorcontrib>Manzano, Pilar</creatorcontrib><creatorcontrib>Ferrins, Lori</creatorcontrib><creatorcontrib>Caffrey, Conor R</creatorcontrib><creatorcontrib>Navarro, Miguel</creatorcontrib><creatorcontrib>Pollastri, Michael P</creatorcontrib><title>Evaluation of a class of isatinoids identified from a high-throughput screen of human kinase inhibitors as anti-Sleeping Sickness agents</title><title>PLoS neglected tropical diseases</title><addtitle>PLoS Negl Trop Dis</addtitle><description>New treatments are needed for neglected tropical diseases (NTDs) such as Human African trypanosomiasis (HAT), Chagas disease, and schistosomiasis. Through a whole organism high-throughput screening campaign, we previously identified 797 human kinase inhibitors that grouped into 59 structural clusters and showed activity against T. brucei, the causative agent of HAT. We herein report the results of further investigation of one of these clusters consisting of substituted isatin derivatives, focusing on establishing structure-activity and -property relationship scope. We also describe their in vitro absorption, distribution, metabolism, and excretion (ADME) properties. For one isatin, NEU-4391, which offered the best activity-property profile, pharmacokinetic parameters were measured in mice.</description><subject>African trypanosomiasis</subject><subject>Antibiotics</subject><subject>Biology</subject><subject>Biology and Life Sciences</subject><subject>Chagas disease</subject><subject>Chemistry</subject><subject>Clinical trials</subject><subject>Clusters</subject><subject>Dosage and administration</subject><subject>Drug therapy</subject><subject>Drugs</subject><subject>Excretion</subject><subject>High-throughput screening</subject><subject>Identification</subject><subject>Inhibitors</subject><subject>Kinase inhibitors</subject><subject>Kinases</subject><subject>Medical treatment</subject><subject>Medicine and Health Sciences</subject><subject>Metabolism</subject><subject>Nervous system</subject><subject>Parasites</subject><subject>Parasitic diseases</subject><subject>Pharmacokinetics</subject><subject>Pharmacology</subject><subject>Schistosomiasis</subject><subject>Tropical climate</subject><subject>Tropical diseases</subject><subject>Trypanosomiasis</subject><subject>Vector-borne diseases</subject><issn>1935-2735</issn><issn>1935-2727</issn><issn>1935-2735</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkm1r1TAUx4sobk6_gWhBEN_0mjRNH94IY0wdDHwxfR1Ok9M2d2lyTdqB38CPbbrbjXtlbaHh9Hf-56H_JHlLyYayin7eutlbMJudndSGEFLRvHmWnNKG8SyvGH9-cD5JXoWwJYQ3vKYvkxNGYpATepr8vbwDM8OknU1dl0IqDYSwHHWIUeu0CqlWaCfdaVRp590YqUH3QzYN3s39sJunNEiPeK8wzCPY9FZbCJhqO-hWT86HFOITRbIbg7jTtk9vtLy1GGtBH9XD6-RFBybgm_V9lvz6evnz4nt2_ePb1cX5dSbLvJgyZHnHS4LxIqxDSeuyAFB1U_OyLWgHkjDW8ZowjtAxijwvct6olihOi6plZ8n7ve7OuCDWJQaR5zxnlBZFHomrPaEcbMXO6xH8H-FAi_uA870AP2lpUNRScqUAataSgmEOSyuqlRRlLA1V1PqyVpvbEZWMk3owR6LHX6weRO_uRMlq1hR1FPi0Cnj3e8YwiVEHicaARTfHvmnNefypOYvoh__Qp6dbqR7iANp2LtaVi6g451XJq7gtGqnNE1S8FY5aOoudjvGjhI8HCQOCmYbgzLwYKxyDxR6U3oXgsXtcBiViMfZD12IxtliNHdPeHS7yMenByewfLE332Q</recordid><startdate>20190201</startdate><enddate>20190201</enddate><creator>Klug, Dana M</creator><creator>Diaz-Gonzalez, Rosario</creator><creator>Pérez-Moreno, Guiomar</creator><creator>Ceballos-Pérez, Gloria</creator><creator>García-Hernández, Raquel</creator><creator>Gomez-Pérez, Veronica</creator><creator>Ruiz-Pérez, Luis Miguel</creator><creator>Rojas-Barros, Domingo I</creator><creator>Gamarro, Francisco</creator><creator>González-Pacanowska, Dolores</creator><creator>Martínez-Martínez, María S</creator><creator>Manzano, Pilar</creator><creator>Ferrins, Lori</creator><creator>Caffrey, Conor R</creator><creator>Navarro, Miguel</creator><creator>Pollastri, Michael P</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7SS</scope><scope>7T2</scope><scope>7T7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>F1W</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>H95</scope><scope>H97</scope><scope>K9.</scope><scope>L.G</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-2301-2699</orcidid><orcidid>https://orcid.org/0000-0001-9943-7197</orcidid><orcidid>https://orcid.org/0000-0002-8982-0640</orcidid></search><sort><creationdate>20190201</creationdate><title>Evaluation of a class of isatinoids identified from a high-throughput screen of human kinase inhibitors as anti-Sleeping Sickness agents</title><author>Klug, Dana M ; Diaz-Gonzalez, Rosario ; Pérez-Moreno, Guiomar ; Ceballos-Pérez, Gloria ; García-Hernández, Raquel ; Gomez-Pérez, Veronica ; Ruiz-Pérez, Luis Miguel ; Rojas-Barros, Domingo I ; Gamarro, Francisco ; González-Pacanowska, Dolores ; Martínez-Martínez, María S ; Manzano, Pilar ; Ferrins, Lori ; Caffrey, Conor R ; Navarro, Miguel ; Pollastri, Michael P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c624t-e32f560eeee03fec1864aad89856b41fac033f58035eaf31e524259db0d5147b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>African trypanosomiasis</topic><topic>Antibiotics</topic><topic>Biology</topic><topic>Biology and Life Sciences</topic><topic>Chagas disease</topic><topic>Chemistry</topic><topic>Clinical trials</topic><topic>Clusters</topic><topic>Dosage and administration</topic><topic>Drug therapy</topic><topic>Drugs</topic><topic>Excretion</topic><topic>High-throughput screening</topic><topic>Identification</topic><topic>Inhibitors</topic><topic>Kinase inhibitors</topic><topic>Kinases</topic><topic>Medical treatment</topic><topic>Medicine and Health Sciences</topic><topic>Metabolism</topic><topic>Nervous system</topic><topic>Parasites</topic><topic>Parasitic diseases</topic><topic>Pharmacokinetics</topic><topic>Pharmacology</topic><topic>Schistosomiasis</topic><topic>Tropical climate</topic><topic>Tropical diseases</topic><topic>Trypanosomiasis</topic><topic>Vector-borne diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Klug, Dana M</creatorcontrib><creatorcontrib>Diaz-Gonzalez, Rosario</creatorcontrib><creatorcontrib>Pérez-Moreno, Guiomar</creatorcontrib><creatorcontrib>Ceballos-Pérez, Gloria</creatorcontrib><creatorcontrib>García-Hernández, Raquel</creatorcontrib><creatorcontrib>Gomez-Pérez, Veronica</creatorcontrib><creatorcontrib>Ruiz-Pérez, Luis Miguel</creatorcontrib><creatorcontrib>Rojas-Barros, Domingo I</creatorcontrib><creatorcontrib>Gamarro, Francisco</creatorcontrib><creatorcontrib>González-Pacanowska, Dolores</creatorcontrib><creatorcontrib>Martínez-Martínez, María S</creatorcontrib><creatorcontrib>Manzano, Pilar</creatorcontrib><creatorcontrib>Ferrins, Lori</creatorcontrib><creatorcontrib>Caffrey, Conor R</creatorcontrib><creatorcontrib>Navarro, Miguel</creatorcontrib><creatorcontrib>Pollastri, Michael P</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 1: Biological Sciences &amp; Living Resources</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 3: Aquatic Pollution &amp; Environmental Quality</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Professional</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>PLoS neglected tropical diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Klug, Dana M</au><au>Diaz-Gonzalez, Rosario</au><au>Pérez-Moreno, Guiomar</au><au>Ceballos-Pérez, Gloria</au><au>García-Hernández, Raquel</au><au>Gomez-Pérez, Veronica</au><au>Ruiz-Pérez, Luis Miguel</au><au>Rojas-Barros, Domingo I</au><au>Gamarro, Francisco</au><au>González-Pacanowska, Dolores</au><au>Martínez-Martínez, María S</au><au>Manzano, Pilar</au><au>Ferrins, Lori</au><au>Caffrey, Conor R</au><au>Navarro, Miguel</au><au>Pollastri, Michael P</au><au>Almeida, Igor C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of a class of isatinoids identified from a high-throughput screen of human kinase inhibitors as anti-Sleeping Sickness agents</atitle><jtitle>PLoS neglected tropical diseases</jtitle><addtitle>PLoS Negl Trop Dis</addtitle><date>2019-02-01</date><risdate>2019</risdate><volume>13</volume><issue>2</issue><spage>e0007129</spage><epage>e0007129</epage><pages>e0007129-e0007129</pages><issn>1935-2735</issn><issn>1935-2727</issn><eissn>1935-2735</eissn><abstract>New treatments are needed for neglected tropical diseases (NTDs) such as Human African trypanosomiasis (HAT), Chagas disease, and schistosomiasis. Through a whole organism high-throughput screening campaign, we previously identified 797 human kinase inhibitors that grouped into 59 structural clusters and showed activity against T. brucei, the causative agent of HAT. We herein report the results of further investigation of one of these clusters consisting of substituted isatin derivatives, focusing on establishing structure-activity and -property relationship scope. We also describe their in vitro absorption, distribution, metabolism, and excretion (ADME) properties. For one isatin, NEU-4391, which offered the best activity-property profile, pharmacokinetic parameters were measured in mice.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>30735501</pmid><doi>10.1371/journal.pntd.0007129</doi><orcidid>https://orcid.org/0000-0003-2301-2699</orcidid><orcidid>https://orcid.org/0000-0001-9943-7197</orcidid><orcidid>https://orcid.org/0000-0002-8982-0640</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1935-2735
ispartof PLoS neglected tropical diseases, 2019-02, Vol.13 (2), p.e0007129-e0007129
issn 1935-2735
1935-2727
1935-2735
language eng
recordid cdi_plos_journals_2252311442
source PubMed Central (Open Access); Publicly Available Content Database
subjects African trypanosomiasis
Antibiotics
Biology
Biology and Life Sciences
Chagas disease
Chemistry
Clinical trials
Clusters
Dosage and administration
Drug therapy
Drugs
Excretion
High-throughput screening
Identification
Inhibitors
Kinase inhibitors
Kinases
Medical treatment
Medicine and Health Sciences
Metabolism
Nervous system
Parasites
Parasitic diseases
Pharmacokinetics
Pharmacology
Schistosomiasis
Tropical climate
Tropical diseases
Trypanosomiasis
Vector-borne diseases
title Evaluation of a class of isatinoids identified from a high-throughput screen of human kinase inhibitors as anti-Sleeping Sickness agents
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T06%3A33%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20a%20class%20of%20isatinoids%20identified%20from%20a%20high-throughput%20screen%20of%20human%20kinase%20inhibitors%20as%20anti-Sleeping%20Sickness%20agents&rft.jtitle=PLoS%20neglected%20tropical%20diseases&rft.au=Klug,%20Dana%20M&rft.date=2019-02-01&rft.volume=13&rft.issue=2&rft.spage=e0007129&rft.epage=e0007129&rft.pages=e0007129-e0007129&rft.issn=1935-2735&rft.eissn=1935-2735&rft_id=info:doi/10.1371/journal.pntd.0007129&rft_dat=%3Cgale_plos_%3EA576572591%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c624t-e32f560eeee03fec1864aad89856b41fac033f58035eaf31e524259db0d5147b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2252311442&rft_id=info:pmid/30735501&rft_galeid=A576572591&rfr_iscdi=true